Merck & Co. To Invest $313 Million in Irish Manufacturing Facilities
MSD, known as Merck & Co., Inc., in the U.S. and Canada, plans to invest EUR 280 million ($313 million) over the next three years at two of its Irish manufacturing sites in Carlow and Cork Counties,Ireland.
MSD in Brinny, County Cork is an integrated site for the development, testing, and manufacturing of biologics, specializing in the fermentation, purification, and sterile filling of biologics, The expansioin will add 220 new positions.
MSD in Carlow is a facility that formulates and fills vaccines and biologics, and the expansion will create 120 new roles. Carlow also is an important link in MSD’s network of sites producing the company’s immuno-oncology treatment for the global market.
MSD currently employs more than 1,600 people across four sites in Ireland: Carlow, Cork, Dublin, and Tipperary. Its Irish operations encompass manufacturing, commercial, global financial services, and marketing facilities,
Source: IDA Ireland